The pronociceptive effect of ondansetron in the setting of P-glycoprotein inhibition

Anesthesia and Analgesia

Volumn 103, Issue 3, 2006, Pages 742-746

  Scott, Jason A ^a   Wood, Margaret ^a   Flood, Pamela ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CYCLOSPORIN; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; ISOFLURANE; ONDANSETRON; QUINIDINE; VALSPODAR; VERAPAMIL; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL TEST; FEMALE; HYPERALGESIA; IMMOBILIZATION; KNOCKOUT MOUSE; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; WILD TYPE; ANIMAL; DRUG ANTAGONISM; LUNG ALVEOLUS; METABOLISM; MOUSE MUTANT; NOCICEPTIVE RECEPTOR; PAIN; SPRAGUE DAWLEY RAT;

ANIMALS; FEMALE; ISOFLURANE; MALE; MICE; MICE, KNOCKOUT; NOCICEPTORS; ONDANSETRON; P-GLYCOPROTEIN; PAIN; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 33749045510     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000228861.80314.22     Document Type: Article

References (15)

1. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996;97:2517-24.
2. Arboix M, Paz OG, Colombo T, D'Incalci M. Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis. J Pharmacol Exp Ther 1997;281:1226-30.
3. Boesch D, Gaveriaux C, Jachez B, et al. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res 1991;51:4226-33.
4. Choo EF, Leake B, Wandel C, et al. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos 2000;28:655-60.
5. Dershwitz M, DiBiase PM, Rosow CE, et al. Ondansetron does not affect alfentanil-induced ventilatory depression or sedation. Anesthesiology 1992;77:447-52.
6. Petersen-Felix S, Arendt-Nielsen L, Bak P, et al. Ondansetron does not inhibit the analgesic effect of alfentanil. Br J Anaesth 1994;73:326-30.
7. Rampil IJ, Laster MJ, Eger EI II. Antagonism of the 5-HT(3) receptor does not alter isoflurane MAC in rats. Anesthesiology 2001;95:562-4.
8. Alhaider AA, Lei SZ, Wilcox GL. Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci 1991;11:1881-8.
9. LoPachin RM, Rudy TA, Yaksh TL. An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiol Behav 1981;27:559-61.
10. Eger EI II, Zhang Y, Laster M, et al. Acetylcholine receptors do not mediate the immobilization produced by inhaled anesthetics. Anesth Analg 2002;94:1500-4.
11. Hargreaves KM, Mueller GP, Dubner R, et al. Corticotropin-releasing factor (CRF) produces analgesia in humans and rats. Brain Res 1987;422:154-7.
12. Furst S. Transmitters involved in antinociception in the spinal cord. Brain Res Bull 1999;48:129-41.
13. Li P, Zhuo M. Cholinergic, noradrenergic, and serotonergic inhibition of fast synaptic transmission in spinal lumbar dorsal horn of rat. Brain Res Bull 2001;54:639-47.
14. Zeitz KP, Guy N, Malmberg AB, et al. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002;22:1010-9.
15. Giordano J, Dyche J. Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse. Neuropharmacology 1989;28:423-7.